Dean F. Bajorin, MD Memorial Sloan-Kettering Cancer Center, Discusses Bladder...
Dr. Dean F. Bajorin, MD Memorial Sloan-Kettering Cancer Center, in New York Discusses Bladder Cancer and Rare GU Tumors at the ASCO Genitourinary Conference in San Francisco. Direct...
View ArticleAndrew X. Zhu, MD, PhD - ASCO GI 2010
Dr Axel Grothey interviews Dr. Andrew X. Zhu from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on...
View ArticleOncoFacts Lung Cancer - ASCO 2010 Overview (Crizotinib,...
Abstract 3 and LBA7502 Crizotinib is a small molecule EML4/ALK and MET inhibitor that was evaluated in a phase II trial that enrolled 82 patients pre-selected by the presence of the EML4/ALK fusion...
View ArticleThomas J. Herzog, MD, Columbia University College of Physicians and Surgeons...
Full interview... http://elc.imedex.com/?proj... * Liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced malignancy * Erlotinib in squamous cell carcinoma... Author: imedex...
View ArticleGastrointestinal Malignancies - OncoFacts from ASCO 2010 (COIN trial,...
Abstracts 3502 and 3525 Investigators from the UK Medical Research Council (MRC) presented results of their COIN trial in which 2500 patients with advanced colorectal cancer were randomized to...
View ArticleDeborah Armstrong, MD, Johns Hopkins Kimmel Cancer Center, discusses Early...
Full interview... http://elc.imedex.com/?proj... * Early studies of enzastaurin and bevacizumab * Single nucleotitde polymorphisms (SNPs) * BRCA1 and association with clinical... Author: imedex Added:...
View ArticleDr. Michael Morris, MD, Memorial Sloan-Kettering Cancer Center discusses...
Dr. Michael Morris, MD, Memorial Sloan-Kettering Cancer Center discusses Novel Therapies for Prostate Cancer at ASCO GU Conference from San Francisco. Direct Link...http://elc.imedex.com/?proj.........
View ArticleESMO 2010 - Dr. Ross Camidge, MD discusses Clinical Activity of Crizotinib...
Dr. Ross Camidge, MD discusses Clinical Activity of Crizotinib (PF-02341066), in ALK-Positive Patients with Non-Small Cell Lung Cancer (NSCLC) Author: esmo2010 Added: 10/10/2010
View ArticleWells Messersmith, MD, ASCO GI 2010
Dr Axel Grothey interviews Dr. Wells Messersmith from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact...
View ArticleDr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, discusses Renal...
Dr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, New York discusses Renal Cell Cancer-Surgical management & high risk disease at the ASCO GU Conference 2010 Direct Link......
View ArticleCathy Eng, MD, FACP, ASCO GI 2010
Dr Axel Grothey interviews Dr. Cathy Eng from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on...
View ArticleDr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, discusses small...
Eighth International Kidney Cancer Symposium - Paul Russo, M.D. For more in this series: http://www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is...
View ArticleAUA 2010 interview of Dr. Tom Lue, MD professor of Urology at UCSF talks...
American Urology Association 2010 interview of Dr. Tom Lue, MD professor of Urology at UCSF talks about Peyronie's disease. Author: imedex Added: 06/01/2010
View ArticleDr Alexander Kamb - Executive Director Oncology for Amgen
Alexander received his AB from Harvard University and his PhD from Caltech. After a postdoctoral fellowship at UCSF, he worked in the biotechnology field for about ten years, specializing in the...
View ArticleM. D. Anderson-Orlando - Breast Reconstruction - Dr. Kenneth Lee
Dr. Kenneth Lee, Plastic Surgeon at M. D. Anderson - Orlando, discusses breast reconstruction surgery and the benefits that patients being treated for breast cancer can expect. Author:...
View Article
More Pages to Explore .....